FDA Asked to Seek Benefits-Risk Assessment Data from Abortion Pill Makers

Pensacola, FL  (June 25, 2025)—FDA Commissioner Marty Makary has recently promised to undertake a new review of the “postmarketing safety data on mifepristone for the medical termination of early pregnancy.” In an open letter to the Commissioner, Elliot Institute director David Reardon, has asked Makary to also direct the FDA to require the abortion pill […]

It’s Time to Focus on Unwanted Abortions

Over 60% of aborting women report they felt pressured to abort contrary to their own preferences. 24% describe their abortions as unwanted or coerced. Unregulated abortion empowers abusers, denies women the help they need to avoid unwanted abortions, and enriches unethical abortion providers. Why aren’t we talking more about the national crisis of unwanted abortions?!! […]

Scroll to top